Research Article
Preventive Effect of the Herbal Preparation, HemoHIM, on Cisplatin-Induced Immune Suppression
Table 2
Effect of HemoHIM on flow cytometric analysis CD4+ and CD8+T lymphocytes in cisplatin-treated mice.
| Group | Splenocyte | Whole blood | CD4+(%) | CD8+(%) | CD4+(%) | CD8+(%) |
| Control | 54.77 ± 1.86 | 36.46 ± 2.66 | 15.04 ± 2.69 | 7.84 ± 2.32 | Cisplatin | 51.91 ± 1.28 | 39.20 ± 2.46 | 14.87 ± 2.76 | 8.87 ± 1.07 | Cisplatin + HemoHIM 100 mg/kg | 53.47 ± 2.39 | 40.36 ± 2.57 | 15.27 ± 2.77 | 8.70 ± 1.54 | Cisplatin + HemoHIM 250 mg/kg | 56.07 ± 2.37 | 39.13 ± 2.49 | 15.63± 1.92 | 9.09 ± 1.57 | Cisplatin + HemoHIM 500 mg/kg | 56.73 ± 3.20 | 38.41 ± 2.39 | 18.94 ± 3.52 | 11.57 ± 2.62 |
|
|
Significant difference from cisplatin group ( p<0.05, p<0.01). |